Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2012
08/08/2012CN102627605A Huperzine A polymorph, its preparation method, medicinal composition containing huperzine A polymorph and its application
08/08/2012CN102627603A Process of making crystalline aripiprazole
08/08/2012CN102626504A Chinese medicinal oral liquid for preventing and treating depression
08/08/2012CN102626503A Chinese medicinal oral liquid for smoothing heart and enhancing intelligence
08/08/2012CN102626497A Traditional Chinese medicine for treating diabetic foot
08/08/2012CN102626488A Gastrodia elata medicine for treating insomnia
08/08/2012CN102626474A Pharmaceutical composition with efficacy of relieving depressed liver and tranquilizing mind
08/08/2012CN102626452A Hawthorn, radix puerariae, gingko and balsam pear four-in-one flavone capsule
08/08/2012CN102626449A Capsule for treating apoplexy hemiplegia
08/08/2012CN102626447A Preparation method of kava lactone
08/08/2012CN102626434A Preparing method for separating and purifying flavonoid compounds from micropore grass seed dregs
08/08/2012CN102626433A Application of ixeris sonchifolia hance injection in preparing medicine for treating dementia
08/08/2012CN102626430A Method for preparing total alkaloid from daphniphyllum calycinum
08/08/2012CN102626428A Ginkgo leaf extract osmotic pump controlled-release preparation and preparation method thereof
08/08/2012CN102626411A Pharmaceutical composition containing propofol and opioid analgesics and use thereof
08/08/2012CN102626396A Metoprolol slow-release tablet and preparation method thereof
08/08/2012CN102626390A Gastrodin multiphase liposome injection
08/08/2012CN102626383A Bilobalide injection and preparation method thereof
08/08/2012CN102626382A Method for preparing sinomenine hydrochloride infusion solution and freeze-dried powder injection
08/08/2012CN102205033B Preparation method of traditional Chinese medicine for treating headache-type influenza in children
08/08/2012CN102205013B Method for processing giant typhonium rhizome
08/08/2012CN102125662B Compound traditional Chinese medicine for treating apoplexia and preparation method and application thereof
08/08/2012CN102058752B Medicament for treating epilepsia and preparation method thereof
08/08/2012CN101961418B Double-controlled release, high-dosage and low-irritation capsaicin compound transdermal patch
08/08/2012CN101940770B Medicament for treating insomnia and preparation method thereof
08/08/2012CN101921229B Synthesis method of stepholidine or derivative optical isomer thereof and intermediate thereof
08/08/2012CN101897952B Application of trefoil factor 3 to preparing medicament for preventing and/or treating depressive disorder
08/08/2012CN101889079B A method for constructing human placental mesenchymal cells library which is suitable for clinical applicationc
08/08/2012CN101883769B Isoxazolo-pyrazine derivatives
08/08/2012CN101766659B Preparation having function of improving memories and preparation method and application thereof
08/08/2012CN101525570B Glossy ganoderma-ginseng sedative wine
08/08/2012CN101479268B 2-0'-methyladenosine derivatives and their use as agonists or antagonists of an adenosine receptor
08/08/2012CN101374529B Method of stabilizing s-adenosyl-l-methionine and stabilized composition
08/08/2012CN101310771B 视觉功能障碍改善剂 Visual dysfunction improving agent
08/08/2012CN101283793B Health-care products for cleaning the fume poison in vivo and its preparation method
08/08/2012CN101195613B Compound with substituted tetratomic ring structure and medicine use thereof
08/08/2012CN101195612B Compound with substituted cyclobutane structure, production method and medicine use thereof
08/08/2012CN101090731B Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder
08/07/2012US8236951 Thioxanthine derivatives as myeloperoxidase inhibitors
08/07/2012US8236947 Quinoline derivatives and their use as 5-HT6 ligands
08/07/2012US8236809 Substituted 1,2,3-triazolopyrimidines for the inhibition of NAD(P)H oxidases and platelet activation
08/07/2012US8236804 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
08/07/2012US8236803 Aza-bicycloalkyl ethers and their use as alpha7-nAChR agonists
08/07/2012US8236798 Carboxamide compounds and their use as calpain inhibitors
08/07/2012US8236351 Tamper-resistant oral opioid agonist formulations
08/07/2012US8236339 Therapeutic delivery of carbon monoxide
08/07/2012US8236285 aerosol sprays; fast onset of effect
08/07/2012US8236282 Benzothiazole derivative compounds, compositions and uses
08/07/2012US8236143 Controlling chemical reactions by spectral chemistry and spectral conditioning
08/07/2012CA2642465C Novel pyrone-indole derivatives and process for their preparation
08/07/2012CA2606861C Stable nanoparticle formulations
08/07/2012CA2568897C Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states
08/07/2012CA2566219C Substituted cyclohexyl-1,4-diamine derivatives with a chain extension
08/07/2012CA2513544C An otorhinological delivery device
08/07/2012CA2489206C Method for producing neural cell
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2429216C Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors
08/07/2012CA2420226C Methods for treating demyelinating diseases
08/07/2012CA2373112C Lactic acid bacteria with anxiolytic properties and uses thereof
08/04/2012CA2766684A1 Dual antagonism of endothelin type a and bradykinin b1 receptors for treating pain and preventing cartilage degradation
08/02/2012WO2012103471A1 Use of potassium channel blockers to treat cerebral palsy
08/02/2012WO2012103415A1 Dosage regimen for the treatment of multiple disorders with botulinum toxins
08/02/2012WO2012103297A1 COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION
08/02/2012WO2012103282A2 Methods and compositions for treating alzheimer's disease
08/02/2012WO2012103019A2 Treating neuropsychiatric disorders
08/02/2012WO2012102583A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012WO2012102580A1 Pharmaceutical composition comprising pyridone derivatives
08/02/2012WO2012102562A2 Composition containing novel 4-ｏ-methylhonokiol derivative as active ingredient for treatment of dementia
08/02/2012WO2012102529A2 Composition for regulating circadian rhythms, composition for diagnosing circadian rhythm disorders and diagnostic kit
08/02/2012WO2012102459A1 Novel benzothiazole and benzisothiazole derivatives having 5-ht6 receptor inhibitory activity, preparation method thereof, and pharmaceutical composition containing same
08/02/2012WO2012102361A1 Aromatase activator
08/02/2012WO2012102360A1 Morphinan derivative
08/02/2012WO2012102100A1 Sense-improving agent
08/02/2012WO2012101564A2 Anti-inflammatory compounds
08/02/2012WO2012101487A1 Di/tri-aza-spiro-c9-c11alkanes
08/02/2012WO2012101060A1 Use of nicotinic acetylcholine receptor alpha 7 activators
08/02/2012WO2012101058A1 4-tolyl-ethynyl-octahydro-indole-1-ester derivatives
08/02/2012WO2012100704A1 Chiral low-toxicity cb1 receptor inhibitor, preparation method therefor, and use thereof
08/02/2012WO2012100436A1 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
08/02/2012WO2012100423A1 Analgesic compounds, methods, and formulations
08/02/2012WO2012100389A1 Triterpenoid saponin compounds, preparation methods and uses thereof
08/02/2012WO2012100347A1 Compositions comprising a prostaglandin for treating neuropsychiatric conditions
08/02/2012WO2012080729A3 Casein kinase 1delta (ck1delta) inhibitors and their use in the treatment of neurodegenerative diseases such as tauopathies
08/02/2012WO2012078519A3 3-acylidene-2-oxoindole derivatives for inhibition of transglutaminase 2
08/02/2012WO2012075393A3 Activators of proteasomal degradation and uses thereof
08/02/2012WO2012075286A9 Intrapulmonary benzodiazepine for the treatment and prevention of seizures
08/02/2012WO2012068109A3 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
08/02/2012WO2012058211A3 Quinazoline derivatives, compositions, and uses related thereto
08/02/2012WO2012054446A3 Combination therapy
08/02/2012WO2012051296A3 Purine-based triazoles
08/02/2012WO2011107653A8 Use of levodopa, carbidopa and entacapone for treating parkinson's disease
08/02/2012WO2011070253A8 Azabicyclo[3.1.0]hex-2-yl derivatives, method for preparing same, and pharmaceutical compositions containing same
08/02/2012US20120197221 Transepidermal drug delivery system containing rivastigmine
08/02/2012US20120196941 Absorption enhancers for drug administration
08/02/2012US20120196939 Therapeutic Compounds
08/02/2012US20120196933 Mexiletine prodrugs
08/02/2012US20120196932 Use of Medium Chain Triglycerides for the Treatment and Prevention of Alzheimer's Disease and Other Diseases Resulting from Reduced Neuronal Metabolism
08/02/2012US20120196931 Treatment for Multiple Sclerosis
08/02/2012US20120196929 Use of Rosmarinic Acid and the Derivaties Thereof to Treat Ciguatera
08/02/2012US20120196925 Therapeutic and Diagnostic Molecules
1 ... 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 ... 1833